Various factors, such as chronic toxic exposure, protein-protein interaction, epigenetic modification (Bi et al., 2021), transcription/translation regulators, post-translational modification and mutation, have been shown to activate Nrf2 chronically in cancer, thus promoting its occurrence, development and metastasis. Here, NFE2L2 is linked to cancer.